AMARIN CORP PLC\UK Increase (Decrease) in Contract with Customer, Liability
AMARIN CORP PLC\UK (AMRN) reported Increase (Decrease) in Contract with Customer, Liability of -$4.85 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2026-03-02
- AMARIN CORP PLC\UK increase (decrease) in contract with customer, liability for the quarter ending 2024-12-31 was $0.00.
- AMARIN CORP PLC\UK increase (decrease) in contract with customer, liability for the quarter ending 2024-09-30 was $0.00.
- AMARIN CORP PLC\UK increase (decrease) in contract with customer, liability for the quarter ending 2024-06-30 was -$4.45M.
- AMARIN CORP PLC\UK increase (decrease) in contract with customer, liability for the quarter ending 2024-03-31 was -$401.00K.
- AMARIN CORP PLC\UK increase (decrease) in contract with customer, liability for fiscal 2024 was -$4.85M.
- AMARIN CORP PLC\UK increase (decrease) in contract with customer, liability for fiscal 2023 was -$10.50M.
- AMARIN CORP PLC\UK increase (decrease) in contract with customer, liability for fiscal 2022 was -$1.36M.
- AMARIN CORP PLC\UK increase (decrease) in contract with customer, liability for fiscal 2021 was -$1.92M.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $0.00 derived: sum of 2 quarters · filed 2026-03-02 | -$4.45M derived: sum of 3 quarters · filed 2026-03-02 | -$4.85M 10-K · filed 2026-03-02 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | -$4.45M derived: sum of 2 quarters · filed 2025-10-29 | -$4.85M 10-Q · filed 2025-10-29 | -$4.97M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-06-30 | -$4.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | -$4.85M 10-Q · filed 2025-07-30 | -$4.97M derived: sum of 3 quarters · filed 2026-03-02 | -$5.36M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-03-31 | -$401.00K 10-Q · filed 2025-05-07 | -$525.00K derived: sum of 2 quarters · filed 2026-03-02 | -$907.00K derived: sum of 3 quarters · filed 2026-03-02 | -$10.45M derived: sum of 4 quarters · filed 2026-03-02 |
| 2023-12-31 | -$124.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$506.00K derived: sum of 2 quarters · filed 2026-03-02 | -$10.05M derived: sum of 3 quarters · filed 2026-03-02 | -$10.50M 10-K · filed 2026-03-02 |
| 2023-09-30 | -$382.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | -$9.93M derived: sum of 2 quarters · filed 2024-10-30 | -$10.37M 10-Q · filed 2024-10-30 | -$10.72M derived: sum of 4 quarters · filed 2025-03-12 |
| 2023-06-30 | -$9.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | -$9.99M 10-Q · filed 2024-07-31 | -$10.34M derived: sum of 3 quarters · filed 2025-03-12 | -$10.65M derived: sum of 4 quarters · filed 2025-03-12 |
| 2023-03-31 | -$445.00K 10-Q · filed 2024-05-01 | -$796.00K derived: sum of 2 quarters · filed 2025-03-12 | -$1.11M derived: sum of 3 quarters · filed 2025-03-12 | -$1.44M derived: sum of 4 quarters · filed 2025-03-12 |
| 2022-12-31 | -$351.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | -$662.00K derived: sum of 2 quarters · filed 2025-03-12 | -$991.00K derived: sum of 3 quarters · filed 2025-03-12 | -$1.36M 10-K · filed 2025-03-12 |
| 2022-09-30 | -$311.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | -$640.00K derived: sum of 2 quarters · filed 2023-11-01 | -$1.01M 10-Q · filed 2023-11-01 | -$1.44M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | -$329.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | -$701.00K 10-Q · filed 2023-08-02 | -$1.12M derived: sum of 3 quarters · filed 2024-02-29 | -$1.46M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | -$372.00K 10-Q · filed 2023-05-03 | -$795.00K derived: sum of 2 quarters · filed 2024-02-29 | -$1.13M derived: sum of 3 quarters · filed 2024-02-29 | -$1.63M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | -$423.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$759.00K derived: sum of 2 quarters · filed 2024-02-29 | -$1.26M derived: sum of 3 quarters · filed 2024-02-29 | -$1.92M 10-K · filed 2024-02-29 |
| 2021-09-30 | -$336.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | -$838.00K derived: sum of 2 quarters · filed 2022-10-27 | -$1.50M 10-Q · filed 2022-10-27 | -$1.77M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | -$502.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | -$1.16M 10-Q · filed 2022-08-03 | -$1.44M derived: sum of 3 quarters · filed 2023-03-01 | -$2.75M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | -$662.00K 10-Q · filed 2022-05-04 | -$935.00K derived: sum of 2 quarters · filed 2023-03-01 | -$2.24M derived: sum of 3 quarters · filed 2023-03-01 | -$3.84M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | -$273.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$1.58M derived: sum of 2 quarters · filed 2023-03-01 | -$3.17M derived: sum of 3 quarters · filed 2023-03-01 | -$2.21M 10-K · filed 2023-03-01 |
| 2020-09-30 | -$1.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$2.90M derived: sum of 2 quarters · filed 2021-11-03 | -$1.94M 10-Q · filed 2021-11-03 | -$674.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | -$1.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$633.00K 10-Q · filed 2021-08-05 | $634.00K derived: sum of 3 quarters · filed 2022-03-01 | $476.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $961.00K 10-Q · filed 2021-04-29 | $2.23M derived: sum of 2 quarters · filed 2022-03-01 | $2.07M derived: sum of 3 quarters · filed 2022-03-01 | $1.64M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $1.11M derived: sum of 2 quarters · filed 2022-03-01 | $683.00K derived: sum of 3 quarters · filed 2022-03-01 | $136.00K 10-K · filed 2022-03-01 |
| 2019-09-30 | -$158.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$584.00K derived: sum of 2 quarters · filed 2020-11-05 | -$1.13M 10-Q · filed 2020-11-05 | -$1.38M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | -$426.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | -$973.00K 10-Q · filed 2020-08-04 | -$1.22M derived: sum of 3 quarters · filed 2021-02-25 | $931.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | -$547.00K 10-Q · filed 2020-04-30 | -$793.00K derived: sum of 2 quarters · filed 2021-02-25 | $1.36M derived: sum of 3 quarters · filed 2021-02-25 | $1.25M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | -$246.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $1.90M derived: sum of 2 quarters · filed 2021-02-25 | $1.80M derived: sum of 3 quarters · filed 2021-02-25 | $1.66M 10-K · filed 2021-02-25 |
| 2018-09-30 | $2.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $2.04M derived: sum of 2 quarters · filed 2019-11-05 | $1.90M 10-Q · filed 2019-11-05 | $1.52M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | -$106.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | -$248.00K 10-Q · filed 2019-07-31 | -$631.00K derived: sum of 3 quarters · filed 2020-02-25 | $1.31M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | -$142.00K 10-Q · filed 2019-05-01 | -$525.00K derived: sum of 2 quarters · filed 2020-02-25 | $1.42M derived: sum of 3 quarters · filed 2020-02-25 | |
| 2017-12-31 | -$383.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $1.56M derived: sum of 2 quarters · filed 2020-02-25 | $1.22M 10-K · filed 2020-02-25 | |
| 2017-09-30 | $1.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $1.60M 10-Q · filed 2018-11-01 | ||
| 2017-06-30 | -$336.00K 10-Q · filed 2018-08-01 | |||
| 2016-12-31 | $884.00K 10-K · filed 2019-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |